Neuburgh Advisers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$12.1M Sell
178,240
-10,336
-5% -$680K 0.38% 55
2019
Q2
$12.5M Sell
188,576
-8,112
-4% -$473K 0.4% 51
2019
Q1
$10.9M Buy
196,688
+33,648
+21% +$2.05M 0.37% 63
2018
Q4
$8.08M Buy
163,040
+576
+0.4% +$35.2K 0.32% 71
2018
Q3
$14M Buy
162,464
+107,264
+194% +$7.64M 0.45% 50
2018
Q2
$3.2M Sell
55,200
-7,520
-12% -$367K 0.11% 167
2018
Q1
$2.53M Buy
62,720
+7,024
+13% +$265K 0.09% 183
2017
Q4
$1.94M Sell
55,696
-6,928
-11% -$230K 0.07% 198
2017
Q3
$2.08M Buy
62,624
+3,200
+5% +$105K 0.08% 188
2017
Q2
$2.06M Sell
59,424
-9,600
-14% -$280K 0.08% 192
2017
Q1
$1.73M Hold
69,024
0.07% 201
2016
Q4
$1.14M Buy
+69,024
New +$1.17M 0.05% 221

Other funds holding TDOC

Neuburgh Advisers's TDOC Position: Q3 2019 in Review

Neuburgh Advisers reduced its Teladoc Health (TDOC) stake by 5.5% in Q3 2019, selling an estimated $680K and leaving 178,240 shares worth $12.1M. The position accounts for 0.38% of the portfolio, ranked #55.

Neuburgh Advisers first reported a position in TDOC in Q4 2016 and has held it in 12 quarters since. The position peaked at $14M in Q3 2018. 377 funds tracked by Wall St. Rank hold TDOC as of Q3 2019.

  • Neuburgh Advisers held 178,240 shares of Teladoc Health worth $12.1M as of Q3 2019.
  • Neuburgh Advisers sold 10,336 Teladoc Health shares in Q3 2019, an estimated $680K.
  • Teladoc Health made up 0.38% of Neuburgh Advisers's portfolio in Q3 2019, its #55 holding.
  • Neuburgh Advisers first reported a position in Teladoc Health in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's Teladoc Health position peaked at $14M in Q3 2018.
  • 377 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.